<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Oncohematology</journal-id><journal-title-group><journal-title xml:lang="en">Oncohematology</journal-title><trans-title-group xml:lang="ru"><trans-title>Онкогематология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1818-8346</issn><issn publication-format="electronic">2413-4023</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">736</article-id><article-id pub-id-type="doi">10.17650/1818-8346-2009-0-2-22-27</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>HEMATOLOGIC MALIGNANCIES: TREATMENT, SUPPORTIVE CARE</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ГЕМОБЛАСТОЗЫ: ЛЕЧЕНИЕ, СОПРОВОДИТЕЛЬНАЯ ТЕРАПИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">To the issue of differential diagnosis of Hodgkin lymphoma and T-phenotype anaplastic large-cell lymphoma (ALCL)</article-title><trans-title-group xml:lang="ru"><trans-title>К вопросу о дифференциальной диагностике лимфомы Ходжкина и анапластической крупноклеточной лимфомы Т-фенотипа</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Semenova</surname><given-names>A. A.</given-names></name><name xml:lang="ru"><surname>Семенова</surname><given-names>А. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Анастасия Александровна Семёнова </p><p>Москва</p></bio><email>89015121170@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Poddubnay</surname><given-names>I. V.</given-names></name><name xml:lang="ru"><surname>Поддубная</surname><given-names>И. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Probatova</surname><given-names>N. A.</given-names></name><name xml:lang="ru"><surname>Пробатова</surname><given-names>Н. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Osmanov</surname><given-names>E. A.</given-names></name><name xml:lang="ru"><surname>Османов</surname><given-names>Е. А.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sorokin</surname><given-names>E. N.</given-names></name><name xml:lang="ru"><surname>Сорокин</surname><given-names>Е. Н.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Moscow</p></bio><bio xml:lang="ru"><p>Москва</p></bio><xref ref-type="aff" rid="aff2"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Russian Academy for Postgraduate Medical Education</institution></aff><aff><institution xml:lang="ru">Кафедра онкологии ГОУ ДПО РМАПО</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">N. N. Blokhin Russian Cancer Research Center, Russian Academy of Medical Sciences</institution></aff><aff><institution xml:lang="ru">ГУ РОНЦ РАМН им. Н. Н. Блохина РАМН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2009-05-27" publication-format="electronic"><day>27</day><month>05</month><year>2009</year></pub-date><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>22</fpage><lpage>27</lpage><history><date date-type="received" iso-8601-date="2022-11-25"><day>25</day><month>11</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-11-25"><day>25</day><month>11</month><year>2022</year></date></history><permissions><copyright-year>2009</copyright-year><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/></permissions><self-uri xlink:href="https://oncohematology.abvpress.ru/ongm/article/view/736">https://oncohematology.abvpress.ru/ongm/article/view/736</self-uri><abstract xml:lang="en"><p>Hodgkin lymphoma differs from anaplastic largecell lymphoma (ALCL) (≪Hodgkin-like≫ variant) by more frequent early stage diseases revealing (46%), mediastinal lymph nodes involvement (69%), softtissue components absence, small number of cases with more than one extranodal organ involvement (15%), ALK-protein absence (100%) and tumor cell B-immunophenotype (PAX 5+). Morphological features: the expressed pironinophilia in tumor cells cytoplasm by Broshe staining in systemic ALCL (T-/0 phenotype), that is rare observed in Hodgkin lymphoma; large tumor cells in systemic ALCL (_-/0 phenotype) have more polymorphic nucleuses with small nucleoluses in comparison with more spherical cells with large nucleoluses in Hodgkin lymphona; intrasinus growth observed almost in a half of cases in systemic ALCL (T-/0 phenotype) does not revealed in Hodgkin lymphoma; tumor tissue fibrosis is a rare observation in systemic ALCL (T-/0 phenotype), while fibrosis and capsule sclerosis are frequent morphological signs in Hodgkin lymphoma.</p></abstract><trans-abstract xml:lang="ru"><p>Лимфома Ходжкина (ЛХ) отличается от анапластической крупноклеточной лимфомы (АККЛ), ≪ходжкиноподобного≫ варианта, большим представительством начальных стадий заболевания (46%), поражением медиастинальных лимфатических узлов (69%), отсутствием мягкотканых компонентов, малым числом случаев с вовлечением в процесс более одного экстранодального органа (15%); отсутствием ALK-белка (100%) и В-иммунофенотипом (РАХ 5+) опухолевых клеток. Морфологические особенности: выраженная пиронинофилия цитоплазмы при окраске по Броше в опухолевых клетках при системной АККЛ Т-/0-фенотипа, что редко наблюдается при ЛХ; крупные опухолевые клетки при системной АККЛ Т-/0-фенотипа имеют полиморфные ядра с мелкими ядрышками по сравнению с более округлыми клетками с крупными ядрышками при ЛХ; внутрисинусный характер роста, наблюдаемый почти в половине случаев при системной АККЛ Т-/0-фенотипа, не встречается при ЛХ; фиброз в опухолевой ткани в единичных наблюдениях при системной АККЛ Т-/0-фенотипа, в то время как при ЛХ грубый фиброз и склероз капсулы – частый морфологический признак.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>анапластическая крупноклеточная лимфома</kwd><kwd>лимфома Ходжкина</kwd><kwd>диагностические критерии</kwd><kwd>иммунофенотипические особенности</kwd><kwd>клиническое течение</kwd><kwd>прогностические группы</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Тумян Г.С. Клиническая и иммуноморфологическая характеристика лимфомы Ходжкина. Автореф. дис. … докт мед. наук. М., 2004. с. 15.</mixed-citation><mixed-citation xml:lang="ru">Тумян Г.С. Клиническая и иммуноморфологическая характеристика лимфомы Ходжкина. Автореф. дис. … докт мед. наук. М., 2004. с. 15.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Harris N.L., Jaffe E.S., Stein H. et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361–92.</mixed-citation><mixed-citation xml:lang="ru">Harris N.L., Jaffe E.S., Stein H. et al. A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. Blood 1994; 84:1361–92.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Kadin M.E. Anaplastic large cell lymphoma and its morphological variants. Cancer Surv 1997;30:77–86.</mixed-citation><mixed-citation xml:lang="ru">Kadin M.E. Anaplastic large cell lymphoma and its morphological variants. Cancer Surv 1997;30:77–86.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Stein H. Primary systemic anaplastic large cell lymphoma (ALCL). In: Human Lymphoma: Clinical Implications of the REAL Classification. Ed. by D.Y. Mason and N.L. Harris). Berlin: Springer-Verlag, 1999.</mixed-citation><mixed-citation xml:lang="ru">Stein H. Primary systemic anaplastic large cell lymphoma (ALCL). In: Human Lymphoma: Clinical Implications of the REAL Classification. Ed. by D.Y. Mason and N.L. Harris). Berlin: Springer-Verlag, 1999.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
